Skip to main content

Table 2 The associations between gout and significant variants of chromosome 1 in replication cohort

From: Polygenic risk score trend and new variants on chromosome 1 are associated with male gout in genome-wide association study

SNP (chr; position; gene)

Gout

Control

OR (95% CI)

p-values

rs7546668 (chr1; 15528628; DNAJC16)

 GG

55 (27.0)

89 (18.8)

2.77 (1.69-4.56)

4.31e-05

 GC

114 (55.9)

227 (48.0)

2.25 (1.47 -3.46)

1.74e-04

 CC

35 (17.2)

157 (33.2)

1.0

 

rs12124078 (chr1; 15543404; DNAJC16)

 AA

55 (26.8)

90 (19.0)

2.60 (1.58-4.26)

1.22e-04

 AG

114 (55.6)

230 (48.6)

2.11 (1.37-3.23)

5.38e-04

 GG

36 (17.6)

153 (32.3)

1.0

 

rs7515244 (chr1;15546891; DNAJC16)

 AA

55 (26.8)

91 (19.2)

2.58 (1.57-4.21)

1.45e-04

 AG

114 (55.6)

229 (48.4)

2.12 (1.38-3.24)

4.99e-04

 GG

36 (17.6)

153 (32.3)

1.0

 

rs10927807 (chr1; 15584515; AGMAT)

 TT

66 (32.4)

74 (15.6)

4.34 (2.68-7.02)

6.62e-10

 TG

100 (49.0)

214 (45.2)

2.28 (1.49-3.47)

1.09e-04

 GG

38 (18.6)

185 (39.1)

1.0

 

rs12129861 (chr:1; 145709377; PDZK1)

 TT

10 (4.90)

31 (6.55)

0.62 (0.30 -1.31)

0.206

 CT

56 (27.45)

176 (37.21)

0.61 (0.43-0.88)

0.008

 CC

138 (67.65)

266 (56.24)

1.0

 

rs1471633 (chr:1; 145711327; PDZK1)

 GG

10 (4.88)

23 (4.86)

0.86 (0.40 -1.86)

0.708

 TG

50 (24.39)

162(34.25)

0.61 (0.42 -0.89)

0.010

 TT

145 (70.73)

288(60.89)

1.0

 

rs1967017 (chr:1;145711421; PDZK1)

 GG

10(4.88)

23(4.86)

0.86 (0.40-1.86)

0.708

 AG

50(24.39)

162(34.25)

0.61 (0.42-0.89)

0.010

 AA

145(70.73)

288(60.89)

1.0

 

rs35880546 (chr:1;145722014; CD160)

 GG

8(3.90)

15(3.17)

1.07 (0.44-2.57)

0.886

 AG

44(21.46)

152(32.14)

0.58 (0.39-0.85)

0.005

 AA

153(74.63)

306(64.69)

1.0

 

rs4970874 (chr:1;145725691; CD160)

 GG

8(3.90)

15(3.17)

1.07 (0.44-2.57)

0.886

 AG

44(21.46)

152(32.14)

0.58 (0.39-0.85)

0.005

 AA

153(74.63)

306(64.69)

1.0

 

rs1471630 (chr:1;145727789; CD160)

 CC

8(3.90)

15(3.17)

1.07 (0.44-2.57)

0.886

 TC

44(21.46)

152(32.14)

0.58 (0.39-0.85)

0.005

 TT

153(74.63)

306(64.69)

1.0

 

rs9286836 (chr:1;145846532; NUDT17)

 A/A

110(53.66)

17(3.59)

39.75 (21.96-71.94)

5.47e-50

 A/C,G

46(22.44)

155(32.77)

1.82 (1.17-2.85)

0.008

 C,G/C,G

49(23.90)

301(63.64)

1.0

 

rs11264341 (chr:1;155179017; TRIM46)

 CC

68(33.17)

47(9.94)

7.12 (4.39-11.53)

2.77e-17

 CT

88(42.93)

185(39.11)

2.34 (1.57-3.48)

2.24e-05

 TT

49(23.90)

241(50.95)

1.0

 

rs4971100 (chr:1;155183255; TRIM46)

 GG

74(36.27)

39(8.25)

10.53 (6.43-17.24)

3.35e-24

 GA

81(39.71)

162(34.25)

2.78 (1.85-4.16)

4.52e-07

 AA

49(24.02)

272(57.51)

1.0

 

rs4072037 (chr:1;155192276; MUC1)

 CC

85(41.46)

29(6.13)

17.13 (10.23-28.68)

2.87e-34

 CT

69(33.66)

146(30.87)

2.76 (1.83-4.17)

8.37e-07

 TT

51(24.88)

298(63.00)

1.0

 

rs2974935 (chr:1;155212052; MTX1)

 GG

86(42.16)

28(5.92)

17.67 (10.52-29.65)

1.05e-34

 GT

66(32.35)

146(30.87)

2.60 (1.72-3.93)

4.05e-06

 TT

52(25.49)

299(63.21)

1.0

 

rs80142782 (chr:1;155515236; ASH1L)

 CC

2(0.98)

9(1.90)

0.55 (0.12-2.57)

0.439

 TC

53(25.85)

94(19.87)

1.39 (0.95-2.05)

0.094

 TT

150(73.17)

370(78.22)

1.0

 
  1. Chr chromosome